1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Mesotheliomas Pleural: new trials by email Literature Review of Mesotheliomas Pleural trials Research Report on Mesotheliomas Pleural
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors Phase 1 : Regorafenib, Phase 1 : Avelumab, Phase 2 : Regorafenib - Colorectal Cancer Not MSI-H or MMR-deficient, GIST | Phase 1 / Phase 2 | Unknown | Institut Bergonié | 747 | 2018-05-04 | 2023-03-03 |
Biliary Tract Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Sarcoma (1) · Stomach Neoplasms (1) · Tertiary Lymphoid Structures (1) · Thyroid Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Turcot syndrome (1)
Adenocarcinoma (1) · Adenoma (1) · Biliary Tract Diseases (1) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1)
Clinical Trials, Phase II as Topic (1) · regorafenib (1)
France (1)
PMID 34965951, PMID 34998048, PMID 40204996, PMID 40579407
2016 (1)